1989 …2024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles
gemcitabine Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Topotecan Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Metabolites Chemical Compounds
oxaliplatin Medicine & Life Sciences
Bioreactors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2006 2024

Drug Monitoring
Hematopoietic Stem Cells
Drug Discovery
Pharmaceutical Preparations
Prostaglandins G
Monoclonal Antibodies

Research Output 1989 2019

Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion

Alharbi, A. F., Kratzke, R. A., D’Cunha, J., Maddaus, M. A., Sanghavi, K. & Kirstein, M. N., Feb 5 2019, In : Cancer chemotherapy and pharmacology. 83, 2, p. 387-391 5 p.

Research output: Contribution to journalArticle

Bronchial Arteries
Intravenous Infusions
4 Citations (Scopus)

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1

Isakson, S. H., Rizzardi, A. E., Coutts, A. W., Carlson, D. F., Kirstein, M. N., Fisher, J., Vitte, J., Williams, K. B., Pluhar, G. E., Dahiya, S., Widemann, B. C., Dombi, E., Rizvi, T., Ratner, N., Messiaen, L., Stemmer-Rachamimov, A. O., Fahrenkrug, S. C., Gutmann, D. H., Giovannini, M., Moertel, C. L. & 2 others, Largaespada, D. A. & Watson, A. L., Dec 1 2018, In : Communications biology. 1, 1, 158.

Research output: Contribution to journalArticle

Open Access
Miniature Swine
Neurofibromatosis 1
mitogen-activated protein kinase
Neurofibromin 1
genetic disorders
8 Citations (Scopus)

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning

Sanghavi, K. J., Wiseman, A., Kirstein, M. N., Cao, Q., Brundage, R., Jensen, K., Rogosheske, J., Kurtzweil, A., Long-Boyle, J., Wagner, J. E., Warlick, E. D., Brunstein, C. G., Weisdorf, D. J. & Jacobson, P. A., Sep 1 2016, In : Translational Research. 175, p. 103-115.e4

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Stem cells
Cell Transplantation
3 Citations (Scopus)
Brain Natriuretic Peptide
Breast Neoplasms
15 Citations (Scopus)

Randomized, blinded trial of vitamin D 3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)

Shapiro, A. C., Adlis, S. A., Robien, K., Kirstein, M. N., Liang, S., Richter, S. A. & Lerner, R. E., Feb 1 2016, In : Breast Cancer Research and Treatment. 155, 3, p. 501-512 12 p.

Research output: Contribution to journalArticle

Aromatase Inhibitors